These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10578128)

  • 1. Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.
    Desaphy JF; Conte Camerino D; Franchini C; Lentini G; Tortorella V; De Luca A
    Br J Pharmacol; 1999 Nov; 128(6):1165-74. PubMed ID: 10578128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia.
    Desaphy JF; Camerino DC; Tortorella V; De Luca A
    Neuromuscul Disord; 1999 May; 9(3):182-9. PubMed ID: 10382914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
    De Luca A; Natuzzi F; Desaphy JF; Loni G; Lentini G; Franchini C; Tortorella V; Camerino DC
    Mol Pharmacol; 2000 Feb; 57(2):268-77. PubMed ID: 10648636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse.
    De Luca A; Pierno S; Natuzzi F; Franchini C; Duranti A; Lentini G; Tortorella V; Jockusch H; Camerino DC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):93-100. PubMed ID: 9223544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
    Cannon SC; Corey DP
    J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels.
    Duranti A; Franchini C; Lentini G; Loiodice F; Tortorella V; De Luca A; Pierno S; Conte Camerino D
    Eur J Med Chem; 2000 Jan; 35(1):147-56. PubMed ID: 10733611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.
    De Luca A; Talon S; De Bellis M; Desaphy JF; Franchini C; Lentini G; Catalano A; Corbo F; Tortorella V; Conte-Camerino D
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):318-27. PubMed ID: 12644906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
    De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
    Desaphy JF; Farinato A; Altamura C; De Bellis M; Imbrici P; Tarantino N; Caccia C; Melloni E; Padoani G; Vailati S; Keywood C; Carratù MR; De Luca A; Conte D; Pierno S
    Exp Neurol; 2020 Jun; 328():113287. PubMed ID: 32205118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
    De Bellis M; Carbonara R; Roussel J; Farinato A; Massari A; Pierno S; Muraglia M; Corbo F; Franchini C; Carratù MR; De Luca A; Conte Camerino D; Desaphy JF
    Neuropharmacology; 2017 Feb; 113(Pt A):206-216. PubMed ID: 27743929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
    Wang GK; Russell C; Wang SY
    J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
    Desaphy JF; De Luca A; Tortorella P; De Vito D; George AL; Conte Camerino D
    Neurology; 2001 Nov; 57(10):1849-57. PubMed ID: 11723275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.
    De Bellis M; Sanarica F; Carocci A; Lentini G; Pierno S; Rolland JF; Conte Camerino D; De Luca A
    Front Pharmacol; 2017; 8():907. PubMed ID: 29379434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.
    Takahashi MP; Cannon SC
    J Physiol; 2001 Dec; 537(Pt 3):701-14. PubMed ID: 11744749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the late sodium current to intracellular sodium and calcium overload in rabbit ventricular myocytes treated by anemone toxin.
    Kornyeyev D; El-Bizri N; Hirakawa R; Nguyen S; Viatchenko-Karpinski S; Yao L; Rajamani S; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(3):H426-35. PubMed ID: 26637557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
    Aoike F; Takahashi MP; Sakoda S
    Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
    Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
    Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
    De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents.
    De Bellis M; De Luca A; Rana F; Cavalluzzi MM; Catalano A; Lentini G; Franchini C; Tortorella V; Conte Camerino D
    Br J Pharmacol; 2006 Oct; 149(3):300-10. PubMed ID: 16921388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
    Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
    Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.